课题基金 / 基金详情

Pro-Resolving Inflammatory Mediators in Neurovascular Gains in Aerobic Training; a phase 2, double-blind, randomized placebo-controlled trial (PRIMiNG-AT2)

Pro-Resolving Inflammatory Mediators in Neurovascular Gains in Aerobic Training; a phase 2, double-blind, randomized placebo-controlled trial (PRIMiNG-AT2)
有氧训练中促进神经血管增益的炎症介质的消除；
批准号：
485524
负责人：
Swardfager Walter L
金额：
$1.46万
依托单位：
Sunnybrook Research Institute (Toronto, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
已结题
起止时间：
2023-03-01 至 2024-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=485524&lang=en
关键词：
Aging Cerebral Small Vessels Coronary Artery Disease Diabetes Inflammation Physical Activity

项目摘要

项目成果

Swardfager Walter L的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
As people age, the risk of developing dementia increases, especially in those with inflammatory conditions like coronary artery disease and type 2 diabetes mellitus. These conditions can lead to small vessel disease in the brain, which contributes to cogn
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pro-Resolving Inflammatory Mediators in Neurovascular Gains in Aerobic Training (PRIMiNG-AT)
Canada Research Chairs - Tier 2
  • 批准号：
    441848
  • 项目类别：
  • 资助金额：
    $43.71万
  • 财政年份：
    2020
  • 负责人：
    Swardfager Walter L
  • 依托单位：
    University of Toronto
Neurocognitive effects of osteocalcin in type 2 diabetes
Relationships between subcortical ischemic vasculopathy, cerebral atrophy and cognitive performance
海外基金